Definium Therapeutics Inc (DFTX)

Finanzdaten der Definium Therapeutics Inc-Aktie (DFTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	26.78%75.08	59.22	47.58	45.67	40.90
Research and Development	17.31%48.67	41.48	33.52	30.98	29.81
Interest Income/Expense	0.96%1.23	1.25	1.27	1.27	2.34
Operating Income/Loss	26.78%-75.08	-59.22	-47.58	-45.67	-40.90
	106.21%-158.99	-77.10	-50.44	-67.27	-42.74
Attributable To Parent	106.21%-158.99	-77.10	-50.44	-67.27	-42.74
Available To Common Stockholders, Basic	106.21%-158.99	-77.10	-50.44	-67.27	-42.74
Basic Average Shares	1.74%110.68	108.79	-	85.89	85.35
Diluted Average Shares	1.74%110.68	108.79	-	85.89	85.35
Basic Earnings Per Share	102.82%-1.44	-0.71	-	-0.78	-0.50
Diluted Earnings Per Share	102.82%-1.44	-0.71	-	-0.78	-0.50